Skip to content

Research on the cognitive function and brain function protection effect of group social intervention on socially isolated SCD patients

Research on the cognitive function and brain function protection effect of group social intervention on socially isolated SCD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080312
Enrollment
Unknown
Registered
2024-01-25
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s disease, Mild Cognitive Impairment, Subjective Cognitive Decline

Interventions

Group social group:Conduct comprehensive social intervention for 3 times/week and 90 minutes/time, consisting of 25 minutes of collective discussion, 35 minutes of collective aerobic dance and 30 minu
Non-group intervention group:One-to-one supervision by experimenters at home for 1-2 weeks, and then it can be reduced to once every two weeks or spot checks. Carry out home training for 90min minutes
conventional care group:Health education for staff at home or by telephone.

Sponsors

Jiangsu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. People aged 45-85; 2. Compared with the previous normal state, the cognitive function of self-feeling is declining, mainly in memory, and has nothing to do with acute events; 3. The individual objective neuropsychological test is normal or fails to meet the diagnostic criteria of MCI; 4. Primary school education or above; 5.Lubben Social Network Scale (LSNS) LSNS-6 is a simplified version, which includes SCD people with a score of 0-12, that is, SCD people who are socially isolated. 6.Informed consent shall be provided by the participant or their legal guardian

Exclusion criteria

Exclusion criteria: 1. Patients with vascular dementia or other organic brain diseases; 2. Modified Hachinski Ischemia Scale score > 4; 3. Those with blindness, deafness, severe speech disorders, etc. who cannot cooperate with cognitive function examination; 4. Those who have a history of drug or alcohol dependence and other substances within the past 6 months; 5. Participating in other cognitive-related clinical studies. 6. Patients are complicated with severe diabetes, cardiovascular diseases, liver diseases, kidney diseases, mental diseases, bone and joint diseases and other diseases; 7. Those who are unable to undergo fMRI due to claustrophobia, metal foreign bodies in their bodies, dentures, etc. 8. Suffering from other diseases and unable to participate in aerobic training or cognitive function examination.

Design outcomes

Primary

MeasureTime frame
Auditory Verbal Learning Test Huashan Version,AVLT-H—N5;Resting-state functional magnetic resonance imaging,rs-fMRI;

Secondary

MeasureTime frame
Mini-Mental State Examination,MMSE;Montreal Cognitive Assessment,MoCA;trail making test,TMT-A,TMT-B;Wechsler Memory Scale-Revised Logical Memory,WMS-RLM;Wechsler Digit Span,WDS;animal fluency test,AFT;Bosten naming test,BNT;Lubben Social Networrk Scale,LSNS-6;Loneliness Scale,Univesity of California at Los Angels,UCLA;Geriatric Depression Scale,GDS;Insomnia Severity Index, ISI;Pittsburg Sleep Quality Index,PSQI;functional activities questionnaire,FAQ;

Countries

China

Contacts

Public ContactZhu Yi

Jiangsu Provincial People's Hospital

ZhuYi1981@njmu.edu.cn+86 137 0516 4030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026